BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

480 related articles for article (PubMed ID: 24127483)

  • 21. Descriptive analysis of genetic aberrations and cell of origin in Richter transformation.
    Chitalia A; Swoboda DM; McCutcheon JN; Ozdemirli M; Khan N; Cheson BD
    Leuk Lymphoma; 2019 Apr; 60(4):971-979. PubMed ID: 30632835
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Richter syndrome: molecular insights and clinical perspectives.
    Rossi D; Gaidano G
    Hematol Oncol; 2009 Mar; 27(1):1-10. PubMed ID: 19206112
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Richter syndrome: pathogenesis and management.
    Rossi D; Gaidano G
    Semin Oncol; 2016 Apr; 43(2):311-9. PubMed ID: 27040710
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Distinct immune signatures in chronic lymphocytic leukemia and Richter syndrome.
    Wang Y; Sinha S; Wellik LE; Secreto CR; Rech KL; Call TG; Parikh SA; Kenderian SS; Muchtar E; Hayman SR; Koehler AB; Van Dyke DL; Leis JF; Slager SL; Dong H; Kay NE; He R; Ding W
    Blood Cancer J; 2021 May; 11(5):86. PubMed ID: 33972504
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Richter syndrome: novel insights into the biology of transformation.
    Parry EM; Ten Hacken E; Wu CJ
    Blood; 2023 Jul; 142(1):11-22. PubMed ID: 36758208
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Active Akt signaling triggers CLL toward Richter transformation via overactivation of Notch1.
    Kohlhaas V; Blakemore SJ; Al-Maarri M; Nickel N; Pal M; Roth A; Hövelmeyer N; Schäfer SC; Knittel G; Lohneis P; Nikolic M; Wiederstein JL; Franitza M; Georgomonolis T; Reinart N; Herling M; Herling C; Hartmann EM; Rosenwald A; Klapper W; Büttner R; Moia R; Rossi D; Boldorini R; Gaidano G; Frenzel LP; Reinhardt HC; Brüning JC; Hallek M; Krüger M; Peifer M; Pallasch CP; Wunderlich FT
    Blood; 2021 Feb; 137(5):646-660. PubMed ID: 33538798
    [TBL] [Abstract][Full Text] [Related]  

  • 27. TP53/PLCG2-mutated diffuse large B-cell lymphoma richter transformation (DLBCL-RT) of CLL with unusual CD2 and PD-1 expression.
    Symes E; Wang P; Lager AM; Bishop MR; Aqil B; Venkataraman G
    Leuk Lymphoma; 2022 Nov; 63(11):2735-2738. PubMed ID: 35719104
    [No Abstract]   [Full Text] [Related]  

  • 28. Richter transformation with c-MYC overexpression: report of three cases.
    Wang L; Aghel A; Peterson B; Wang-Rodriguez J; Wang HY; Zhao XF
    Int J Clin Exp Pathol; 2015; 8(6):7540-6. PubMed ID: 26261666
    [TBL] [Abstract][Full Text] [Related]  

  • 29. IgVH mutational status and clonality analysis of Richter's transformation: diffuse large B-cell lymphoma and Hodgkin lymphoma in association with B-cell chronic lymphocytic leukemia (B-CLL) represent 2 different pathways of disease evolution.
    Mao Z; Quintanilla-Martinez L; Raffeld M; Richter M; Krugmann J; Burek C; Hartmann E; Rudiger T; Jaffe ES; Müller-Hermelink HK; Ott G; Fend F; Rosenwald A
    Am J Surg Pathol; 2007 Oct; 31(10):1605-14. PubMed ID: 17895764
    [TBL] [Abstract][Full Text] [Related]  

  • 30. U-RT1 - A new model for Richter transformation.
    Schmid T; Maier J; Martin M; Tasdogan A; Tausch E; Barth TFE; Stilgenbauer S; Bloehdorn J; Möller P; Mellert K
    Neoplasia; 2021 Jan; 23(1):140-148. PubMed ID: 33316538
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Richter transformation of chronic lymphocytic leukemia in the era of novel agents.
    Wang Y; Ding W
    Clin Adv Hematol Oncol; 2020 Jun; 18(6):348-357. PubMed ID: 32649656
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Richter syndrome.
    Rossi D; Gaidano G
    Adv Exp Med Biol; 2013; 792():173-91. PubMed ID: 24014297
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Clonality relatedness and molecular characteristics of Richter transformation].
    Sha YQ; Jiang R; Miao Y; Qiu TL; Qin SC; Qiu JY; Mi HL; Wu W; Qiao C; Wu YJ; Xia Y; Wang L; Fan L; Xu W; Li JY; Zhu HY
    Zhonghua Xue Ye Xue Za Zhi; 2022 Oct; 43(10):841-847. PubMed ID: 36709198
    [No Abstract]   [Full Text] [Related]  

  • 34. Treatment of Richter's Syndrome.
    Condoluci A; Rossi D
    Curr Treat Options Oncol; 2017 Nov; 18(12):75. PubMed ID: 29159711
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Multiple cell cycle regulator alterations in Richter's transformation of chronic lymphocytic leukemia.
    Cobo F; Martínez A; Pinyol M; Hernández L; Gómez M; Beá S; Esteve J; Rozman M; Bosch F; López-Guillermo A; Montserrat E; Campo E
    Leukemia; 2002 Jun; 16(6):1028-34. PubMed ID: 12040434
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Stereotyped B-cell receptor is an independent risk factor of chronic lymphocytic leukemia transformation to Richter syndrome.
    Rossi D; Spina V; Cerri M; Rasi S; Deambrogi C; De Paoli L; Laurenti L; Maffei R; Forconi F; Bertoni F; Zucca E; Agostinelli C; Cabras A; Lucioni M; Martini M; Magni M; Deaglio S; Ladetto M; Nomdedeu JF; Besson C; Ramponi A; Canzonieri V; Paulli M; Marasca R; Larocca LM; Carbone A; Pileri SA; Gattei V; Gaidano G
    Clin Cancer Res; 2009 Jul; 15(13):4415-22. PubMed ID: 19509140
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Analysis of the immunoglobulin heavy chain gene of secondary diffuse large B-cell lymphoma that subsequently developed in four cases with B-cell chronic lymphocytic leukemia or lymphoplasmacytoid lymphoma (Richter syndrome).
    Nakamura N; Kuze T; Hashimoto Y; Hoshi S; Tominaga K; Sasaki Y; Shirakawa A; Sato M; Maeda K; Abe M
    Pathol Int; 2000 Aug; 50(8):636-43. PubMed ID: 10972862
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Hodgkin's variant of Richter transformation in chronic lymphocytic leukemia; a retrospective study from the Israeli CLL study group.
    Tadmor T; Shvidel L; Goldschmidt N; Ruchlemer R; Fineman R; Bairey O; Rahimi-Levene N; Herishanu Y; Yuklea M; Arad A; Aviv A; Polliack A
    Anticancer Res; 2014 Feb; 34(2):785-90. PubMed ID: 24511013
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Progression and transformation of chronic lymphocytic leukemia/small lymphocytic lymphoma and B-cell prolymphocytic leukemia: Report from the 2021 SH/EAHP Workshop.
    Czader M; Amador C; Cook JR; Thakkar D; Parker C; Dave SS; Dogan A; Duffield AS; Nejati R; Ott G; Xiao W; Wasik M; Goodlad JR
    Am J Clin Pathol; 2023 Jun; 159(6):554-571. PubMed ID: 37052539
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Clinical outcome and prognostic factors of patients with Richter syndrome: real-world study of the Spanish Chronic Lymphocytic Leukemia Study Group (GELLC).
    Abrisqueta P; Delgado J; Alcoceba M; Oliveira AC; Loscertales J; Hernández-Rivas JA; Ferrà C; Cordoba R; Yáñez L; Medina A; Motlló C; Iacoboni G; Villacampa G; González M; Bosch F
    Br J Haematol; 2020 Sep; 190(6):854-863. PubMed ID: 32519351
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 24.